441 – 450 of 1730
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment
(
- Contribution to journal › Scientific review
-
Mark
Editorial: Long-term Complications after COVID-19 Infections : Optimal Management Remains Unclear – International Cross-Sectional Collaboration Is Necessary
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Aspirin and NSAID use and the risk of COVID-19
2021)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications
(
- Contribution to journal › Article
- 2020
-
Mark
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial
(
- Contribution to journal › Article
-
Mark
Rapid detection of antibiotic resistance in positive blood cultures by MALDI-TOF MS and an automated and optimized MBT-ASTRA protocol for Escherichia coli and Klebsiella pneumoniae
(
- Contribution to journal › Article
-
Mark
Gaps between current clinical practice and evidence-based guidelines for treatment and care of older patients with Community Acquired Pneumonia : a descriptive cross-sectional study
(
- Contribution to journal › Article
-
Mark
Sex-based differences in ED management of critically ill patients with sepsis : a nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Antiretroviral treatment for HIV infection : Swedish recommendations 2019
(
- Contribution to journal › Scientific review
-
Mark
Microgels and hydrogels as delivery systems for antimicrobial peptides
(
- Contribution to journal › Article